Cherie Perez

1.3k total citations
16 papers, 955 citations indexed

About

Cherie Perez is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Cherie Perez has authored 16 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Cherie Perez's work include Prostate Cancer Treatment and Research (6 papers), Renal cell carcinoma treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Cherie Perez is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Renal cell carcinoma treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Cherie Perez collaborates with scholars based in United States, Spain and Germany. Cherie Perez's co-authors include Lance C. Pagliaro, Christopher J. Logothetis, Danai Daliani, Christos N. Papandreou, Shi‐Ming Tu, Hong Yang, Christine Pien, Xuemei Wang, Jeri Kim and Alexandria Petrusich and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Cherie Perez

15 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cherie Perez United States	9	419	314	198	192	187	16	955
Spyridoula Derka Greece	21	381 0.9×	418 1.3×	88 0.4×	126 0.7×	149 0.8×	52	1.1k
Vali Papadimitrakopoulou United States	16	501 1.2×	558 1.8×	257 1.3×	358 1.9×	23 0.1×	21	1.3k
Jan Kornafel Poland	16	246 0.6×	411 1.3×	90 0.5×	13 0.1×	67 0.4×	73	832
Jingao Li China	18	329 0.8×	297 0.9×	338 1.7×	45 0.2×	18 0.1×	85	1.1k
Vera Balz Germany	17	331 0.8×	364 1.2×	49 0.2×	22 0.1×	32 0.2×	38	838
Sandeep K. Singhal United States	18	292 0.7×	592 1.9×	195 1.0×	189 1.0×	16 0.1×	55	1.2k
Preston D. Steen United States	18	259 0.6×	579 1.8×	329 1.7×	5 0.0×	79 0.4×	47	1.0k
Camilla Böckelman Finland	21	546 1.3×	748 2.4×	271 1.4×	15 0.1×	47 0.3×	61	1.4k
Qingfang Li China	17	437 1.0×	336 1.1×	222 1.1×	10 0.1×	55 0.3×	37	1.0k
N. de Vries Netherlands	16	213 0.5×	442 1.4×	165 0.8×	75 0.4×	4 0.0×	23	848

Countries citing papers authored by Cherie Perez

Since Specialization

Citations

This map shows the geographic impact of Cherie Perez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherie Perez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherie Perez more than expected).

Fields of papers citing papers by Cherie Perez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherie Perez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherie Perez. The network helps show where Cherie Perez may publish in the future.

Co-authorship network of co-authors of Cherie Perez

This figure shows the co-authorship network connecting the top 25 collaborators of Cherie Perez. A scholar is included among the top collaborators of Cherie Perez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherie Perez. Cherie Perez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Perez, Cherie, Mark Agulnik, A. Dekker, et al.. (2011). Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent and/or metastatic squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 29(15_suppl). 5517–5517. 2 indexed citations

Mao, Shifeng, Danai Daliani, Xuemei Wang, et al.. (2007). Employing the treatment‐free interval of intermittent androgen ablation to screen candidate prostate cancer therapies. The Prostate. 67(15). 1677–1685. 3 indexed citations

Pagliaro, Lance C., Cherie Perez, Shi‐Ming Tu, & Danai Daliani. (2006). Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 24(6). 487–491. 8 indexed citations

Papandreou, Christos N., Danai Daliani, Darrell Nix, et al.. (2004). Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 22(11). 2108–2121. 372 indexed citations

Mathew, Paul, Peter F. Thall, Donnah Jones, et al.. (2004). Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 22(16). 3323–3329. 101 indexed citations

Perez, Cherie, et al.. (2003). Clinical Aromatherapy Part I: An Introduction Into Nursing Practice. Clinical journal of oncology nursing. 7(5). 595–596. 8 indexed citations

Wood, Laura S., et al.. (2003). The Emergence of Thalidomide in Treating Advanced Renal Cell Carcinoma. Oncology nursing forum. 30(3). 501–511. 1 indexed citations

Amato, Robert J., Cherie Perez, & Lance C. Pagliaro. (2002). Irofulven, a Novel Inhibitor of DNA Synthesis, in Metastatic Renal Cell Cancer. Investigational New Drugs. 20(4). 413–417. 10 indexed citations

Daliani, Danai, Christos N. Papandreou, Peter F. Thall, et al.. (2002). A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma. Cancer. 95(4). 758–765. 54 indexed citations

10.

Pollack, Alan, S B Paryani, Cherie Perez, et al.. (2000). Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria.. PubMed. 215 Suppl. 1401–12. 3 indexed citations

11.

Lee, J. Jack, Waun Ki Hong, Walter N. Hittelman, et al.. (2000). Predicting cancer development in oral leukoplakia: ten years of translational research.. PubMed. 6(5). 1702–10. 301 indexed citations

12.

Hanks, Gerald E., et al.. (1993). Prostatic specific antigen confirmation of long term cure of prostate cancer treated by external beam radiation in the RTOG. International Journal of Radiation Oncology*Biology*Physics. 27. 192–192. 7 indexed citations

13.

Birch, Robert, G Omura, F. Anthony Greco, & Cherie Perez. (1988). Patterns of failure in combined chemotherapy and radiotherapy for limited small cell lung cancer: Southeastern Cancer Study Group experience.. PubMed. 265–70. 13 indexed citations

14.

Pilepich, Miljenko V., et al.. (1987). Radiation therapy in the treatment of chemodectomas. The Laryngoscope. 97(11). 1331–1335. 71 indexed citations

15.

Thomas, Patrick R., et al.. (1984). Late Effects of Treatment for Wilms’ Tumor. The Journal of Urology. 131(2). 409–410.

16.

Perez, Cherie, Hywel Madoc‐Jones, John M. Bedwinek, et al.. (1980). Analysis of recurrences after irradiation of carcinoma of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 6(10). 1426–1427. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact